Search for Clinical Trial Results
Diffuse Cutaneous Systemic Sclerosis - 25 Studies Found
Status | Study |
Recruiting |
Study Name: Serial Night Time Position Splint on Systemic Sclerosis Condition: Diffuse Systemic Sclerosis Date: 2012-04-25 Interventions:
|
Completed |
Study Name: Recombinant Human Relaxin in the Treatment of Diffuse Scleroderma Condition: Systemic Sclerosis Date: 2008-06-23 Interventions:
|
Recruiting |
Study Name: Atorvastatin for Microvascular Endothelial Function and Raynaud in Early Diffuse Scleroderma Condition: Scleroderma Date: 2015-01-26 Interventions:
|
Recruiting |
Study Name: Effectiveness and Safety of SAR156597 in Treating Diffuse Systemic Sclerosis Condition: Systemic Sclerosis Date: 2016-09-30 Interventions:
|
Completed |
Study Name: Fresolimumab In Systemic Sclerosis Condition: Diffuse Systemic Sclerosis Date: 2011-01-25 Interventions: Drug: Fresolimumab intravenous fresolimumab 1mg/kg, first 8 patients; 5 mg/kg following 8 patients |
Active, not recruiting |
Study Name: IVIG Treatment in Systemic Sclerosis Condition:
Date: 2013-01-28 Interventions: Biological: Privigen Subjects will receive 2 g/kg/mo of Privigen® for 6 months if randomized to the |
Terminated |
Study Name: Proof of Concept Trial of Gleevec (Imatinib) in Active Diffuse Scleroderma Condition: Scleroderma Date: 2012-03-01 Interventions:
|
Recruiting |
Study Name: Autologous Stem Cell Transplantation for Progressive Systemic Sclerosis Condition:
|
Recruiting |
Study Name: Autologous SCT for Progressive Systemic Sclerosis: a Prospective NIS Study Condition: Autoimmune Diseases Date: 2014-09-26 Interventions: Procedure: Autologous HSCT 1st AHSCT |
Completed |
Study Name: Study of Ambrisentan With Antifibrotic Agent Combination Therapy in Diffuse Systemic Sclerosis Condition:
Date: 2010-03-24 Interventions: Drug: Ambrisentan Drug is dispensed in tablet form. Ambris |